COVID-19 Vaccines

Pennsylvania will dedicate the newly approved single-dose Johnson & Johnson vaccine to teachers and staff.

Biden noted that vaccine supply was only one bottleneck toward that goal and that the new challenge will be injecting doses into arms as swiftly as possible.

The city is recommending vaccine providers use this single-dose vaccine for people who are hard to reach, like people who are homebound.

With the opening of a FEMA-backed vaccination site at the Convention Center, Philadelphia officials hope to focus resources on standing community clinics.

Lack of proper protections at the pandemic’s start eroded these Black health workers’ trust in medical systems. But they’re still getting vaccinated.

The Philadelphia Health Department is canceling “hundreds” of appointments for people who aren’t in Phase 1A or 1B — and is working on a fix for the form.

New Jersey is also opening up vaccine eligibility for members of the state’s tribal communities and people experiencing homelessness.

Online sign-up forms are frustrating many people, especially older ones now eligible for vaccines. WHYY’s Health Desk Help Desk spoke to a few of you.

It’ll be open every day and stick around at least six weeks, officials say.

Health officials hope new guidance will help more people complete their second shot of the vaccine before starting others on their first dose.

A study says N.J. Latinos are increasingly willing to get vaccinated against COVID-19, but one Latino advocate is concerned about lack of efforts to reach his community.

After daylong discussions, the FDA panelists voted unanimously that the benefits of the vaccine outweighed the risks for adults.

New Jersey has named the five additional cities that are part of its community-based vaccination program. New Jersey-based Johnson & Johnson awaits vaccine approval.

The challenge will be explaining how protective the J&J shot is after the astounding success of the first U.S. vaccines.

Because of supply issues, the county has administered more than 18,400 first doses and more than 9,000 second doses to date.